FDA Investigator Marcia Gelber
Marcia Gelber has conducted inspections on 4 sites in 1 countries as of 26 Apr 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
26 Apr 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Marcia Gelber:
Addam S Reynolds,
Beth F Fritsch,
Bonita S Chester,
Carol F Robinson,
CDR Thomas R Berry, PPh,
Dawn L Wydner,
Denise M Visco, Investigator,
Doreen P Gubbay,
Dorothy J Denes,
Frederick F Razzaghi,
Gabriel R Mclemore,
Geraldine D Sanders,
Gideon N Esuzor,
Hai Lient Phung,
Jacqueline D Mitchell,
Jamirya S Weatherly,
Jason F Chancey,
John Dan,
Johnetta F Walters,
Joseph F Owens,
Joseph L Despins, PhD,
Justine Tomasso,
Kendra A Biddick,
Kendra L Brooks,
Leah M Andrews,
Loretta Nemchik,
LT Tamara J Henderson,
Luis Mburgos Medero,
Mike M Rashti,
Paul L Bellamy,
Penny H Mccarver,
Rachael L Cook,
Robin R Waller,
Russell J Glapion,
Shirley Brown,
Shirley S Brown,
Steven J Rush,
Vanessa E Coulter,
Veronica Fuentes, MS,
Vicky C Stoakes
Marcia Gelber's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2014 | FDA 483 | GE Healthcare, Inc. - Form 483, 2014-07-25 |
July, 2014 | FDA 483 Response | GE Healthcare, Inc. - Form 483R, 2014-08-12 |
April, 2011 | EIR | Azur Pharma, Inc. - EIR, 2011-04-01 |
July, 2014 | EIR | GE Healthcare, Inc. - EIR, 2014-07-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more